Edaravone (Radicut Bag) JA (Edaravone Vials) 30mg/100ml

Edaravone 30mg/100ml vials provide antioxidant support for neurological conditions. Used as a neuroprotective agent in clinical settings. Suitable for ambient storage and available in 10-vial packs. A prescription medication designed to address oxidative stress in specific medical contexts.

Strength

30mg/100ml

Pack Size

10s

Storage

Ambient

Manufacturer / TM Owner

Nichi-Iko Pharmaceutical Co., Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Edaravone 30mg/100ml vials are used to support neurological health by reducing oxidative stress. It is commonly prescribed for conditions involving nerve cell protection. The medication works by neutralizing free radicals that may contribute to cellular damage. Often used in protocols for neurodegenerative support.

Side Effects

Edaravone may help mitigate symptoms associated with oxidative stress in neurological pathways. Users often report improved stability in motor functions during treatment. The medication’s effects are typically observed over time with consistent use. Some patients experience reduced progression of certain neurological symptoms.

Precautions & Warnings

Store edaravone vials at room temperature away from direct light. Keep out of reach of children and pets. Avoid exposure to extreme temperatures or moisture. Consult a healthcare provider before use if pregnant, nursing, or managing chronic conditions. Discard unused portions as directed.

Avoid Interactions

Edaravone may interact with medications affecting liver enzymes or blood pressure. Alcohol consumption should be minimized during treatment. Caution is advised when combining with other neuroactive substances. Always inform your healthcare provider about all medications and supplements in use.

References

Frequently Asked Questions

Edaravone is used to support neurological health by reducing oxidative stress in certain medical conditions.

Store edaravone vials at room temperature, away from light and moisture.

Consult a healthcare provider before combining edaravone with other drugs to avoid potential interactions.

No, edaravone is a prescription medication and requires medical authorization for use.

Side effects may include headache, nausea, or infusion-related reactions; report persistent issues to a doctor.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.